Clinical Trials on Relapsed or Refractory Peripheral T-Cell Lymphoma
Total 3296 results
-
Tianjin Medical University Cancer Institute and...Simcere Pharmaceutical Co., LtdUnknown
-
TakedaCompletedRelapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell LymphomaJapan
-
Chinese PLA General HospitalRecruitingAdvanced Lymphoma | Newly Diagnosed | nk/T-cell LymphomaChina
-
Samsung Medical CenterAsan Medical Center; Yonsei University; Seoul National University; Chonnam National...CompletedExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeKorea, Republic of
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Hodgkin Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | T-Cell Chronic Lymphocytic Leukemia | Recurrent Childhood Non-Hodgkin... and other conditionsUnited States, Germany
-
Instituto de Investigación Biomédica de SalamancaCarlos III Health InstituteRecruitingCutaneous T-Cell LymphomaSpain
-
Rong TaoCompletedSocial Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL PatientsExtranodal NK-T-Cell Lymphoma, Nasal TypeChina
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; 307 Hospital of PLA; Qilu Hospital of Shandong... and other collaboratorsUnknownExtranodal Natural Killer/T-Cell Lymphoma, Nasal TypeChina
-
Mingzhi ZhangShanxi Province Cancer Hospital; Wuhan University; Qingdao University; Wuhan Union... and other collaboratorsUnknownNasal and Nasal-type NK/T-cell LymphomaChina
-
Boston UniversityLigand PharmaceuticalsCompletedCutaneous T-Cell LymphomaUnited States
-
Ruijin HospitalRecruitingNK/T-cell LymphomaChina
-
Huazhong University of Science and TechnologyPeking University People's Hospital; West China Hospital; Ruijin HospitalCompletedT-cell Lymphoma Adults
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminated
-
Samsung Medical CenterCompletedNon-Hodgkin T-cell LymphomaKorea, Republic of
-
Air Force Military Medical University, ChinaUnknown
-
Sun Yat-sen UniversityRecruitingNatural Killer T-cell LymphomaChina
-
Peking UniversityUnknown
-
Centocor Ortho Biotech Services, L.L.C.CompletedHepatosplenic T-cell LymphomaNetherlands
-
Fudan UniversityUnknown
-
Fudan UniversityUnknown
-
Kyowa Kirin, Inc.CompletedCutaneous T-Cell LymphomaUnited States, Spain, France, Australia, Switzerland, United Kingdom, Japan, Denmark, Germany, Italy, Netherlands
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedExtranodal NK-T-Cell Lymphoma, Nasal TypeChina
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
Novartis PharmaceuticalsTerminatedCutaneous T-Cell LymphomaUnited States
-
Sorrento Therapeutics, Inc.WithdrawnDiffuse Large B Cell Lymphoma | Biliary Tract Cancer | Peripheral T Cell Lymphoma | Extranodal NK T Cell Lymphoma, Nasal
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedExtranodal NK-T-Cell Lymphoma, Nasal TypeChina
-
Mingzhi ZhangShanxi Province Cancer Hospital; Wuhan University; Qingdao University; Wuhan Union... and other collaboratorsUnknownNasal and Nasal-type NK/T-cell LymphomaChina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPeripheral T-cell Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Adult Nasal Type Extranodal NK/T-cell Lymphoma | Hepatosplenic T-cell Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult T-cell Leukemia/Lymphoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingNK/T-Cell Lymphoma of Nasal Cavity (Diagnosis) | NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)United States
-
Dartmouth-Hitchcock Medical CenterActive, not recruitingCutaneous T Cell Lymphoma | Graft Versus Host DiseaseUnited States
-
Asana BioSciencesTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Cancer | Lymphoma, Malignant | Myelofibrosis | Lymphoma, Mantle-Cell | Chronic Lymphocytic Leukemia | Peripheral T-Cell Lymphoma | Tumor | Neoplasm | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | Idiopathic Myelofibrosis and other conditionsUnited States, Argentina
-
Zhejiang Cancer HospitalUnknownAngioimmunoblastic T-cell Lymphoma | Chemotherapy Effect | Chemotherapeutic ToxicityChina
-
Sun Yat-sen UniversityRecruitingExtranodal Natural Killer T Cell LymphomaChina
-
Peking University First HospitalPeking University Third Hospital; Peking University Cancer Hospital & InstituteRecruitingCutaneous T Cell Lymphoma | Cutaneous T-Cell Lymphoma/Mycosis FungoidesChina
-
AmgenCompletedType II Refractory Celiac Disease (RCD-II) | In-situ Small Bowel T-cell LymphomaSpain, United States, Finland, France, Netherlands
-
Nevada Cancer InstituteCLL TopicsTerminatedB Cell Lymphoma | T Cell LymphomaUnited States
-
Huiqiang HuangSun Yat-sen UniversityRecruitingExtranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
City of Hope Medical CenterWithdrawnSezary Syndrome | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Folliculotropic Mycosis Fungoides | CD30-Positive Neoplastic Cells Present | Refractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
Ruijin HospitalNot yet recruiting
-
CStone PharmaceuticalsCompletedExtranodal Natural Killer/T-Cell LymphomaChina
-
CelgeneActive, not recruiting
-
The Lymphoma Academic Research OrganisationCompletedT-cell LymphomaFrance, Belgium
-
Kyowa Kirin Co., Ltd.CompletedPeripheral T/NK-cell LymphomaJapan
-
Fundació Institut de Recerca de l'Hospital de la...Instituto de Salud Carlos III; Josep Carreras Leukaemia Research InstituteRecruitingHodgkin Lymphoma, Adult | T Cell LymphomaSpain
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
SCRI Development Innovations, LLCInfinity Pharmaceuticals, Inc.CompletedStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesLymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States, Germany, Italy
-
Samsung Medical CenterCompletedRelapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaKorea, Republic of
-
Stanford UniversityTerminatedCutaneous T-cell Lymphoma | Cutaneous LymphomaUnited States